Our Team at DCAT Week 2025

Deepak Sapra
CEO, Pharmaceutical Services & Active Ingredients

Gunjan Singh
Vice President and Head, API - Mature Markets

Kalpesh Modi
Vice President, and Head – EU Market, API & B2B Collaborations

Dr. NM Sekhar
Vice President, API R&D

E Sreedhar
Executive Vice President, API Regulatory Affairs

Juli Asmonga
Associate Vice President, API Sales & Marketing - North America

Lalitha Kumari
Head API Product Management and Regional Sales Lead - US & Canada

Dileep Kumar K
Director, API Sales & Marketing - North America
About Dr.Reddy’s API Business
We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.
Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.
-
250+ APIs
-
8 Manufacturing sites
-
1900 drug master files across global markets.
-
Over 170 ANDAs and 500 DMFs
-
More than 1000 patents field, and more than 70 own patents granted
-
Experience with complex APIs and formulations supporting early market entries.
-
Preferred pharma API supplier for pharma companies in more than 80 countries.
Sustainability
Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.
What we achieved in the past year:
Our Achievement (awards)

25/04/2024
USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”


05/04/2024
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya


05/12/2023
Dr. Reddy's Pioneers Pharma Advancements Through Strategic Partnerships and Innovation: A Glimpse into Vision 2030: Growth Trajectory and Opportunities for Indian Pharma


04/11/2022
Dr. Reddy’s API received the excellence in API – Technical Documentation award at Aché Laboratórios Parcerias para a Excelência (Partnerships – Excellence) event!


03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021


03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021


11/11/2021
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards


19/10/2020
Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

Our Plants


About DCAT Week 2025
DCAT Week, hosted annually in New York City by the Drug, Chemical & Associated Technologies Association (DCAT), is the premier gathering for companies engaged in the global bio/pharmaceutical manufacturing value chain. It brings together over 10,000 industry professionals from across the world to foster collaboration, drive strategic business development, and shape the future of the bio/pharmaceutical industry.
DCAT is a not-for-profit, volunteer-led organization committed to the growth and advancement of its global membership. Joining DCAT and participating in DCAT Week isn’t just an event—it’s an investment in your company’s future within this dynamic and evolving industry. DCAT Week attracts key decision-makers from across the bio/pharmaceutical value chain, including professionals in sourcing, procurement, business development, corporate support, and licensing. The event serves as a hub for leaders looking to strengthen relationships, explore new business opportunities, showcase capabilities, and drive strategic objectives.
Renuncia
Ninguna información en este sitio web, incluyendo cualquier referencia a cualquier producto o servicio, constituye una oferta de venta ni se interpretará como tal. Los productos protegidos por patentes válidas no se ofrecen ni suministran para uso comercial. Sin embargo, en ciertos casos, a discreción exclusiva de Dr. Reddy's y sujeto a los requisitos legales locales, las cantidades de investigación de dichos productos pueden ofrecerse para fines de presentaciones regulatorias según la Sección 107A de la Ley de Patentes de la India (exención de Bolar), donde existan dichas exenciones regulatorias. Los compradores deben realizar su propia evaluación del producto o servicio, incluyendo el escenario de patentes en sus respectivos mercados, y serán responsables de todas las responsabilidades relacionadas con las patentes. Dr. Reddy's renuncia a todas las garantías, expresas o implícitas, incluyendo, entre otras, las garantías de comerciabilidad, idoneidad para un propósito particular y no infracción.